Prairie Village, KS – July 12, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Emily Holliday has joined the company as Vice President of Human Resources. A seasoned executive with over 20 years of human resources (HR) experience, Holliday will lead HR at Artio and lead the company’s efforts to recruit, develop, and retain top

Read More

Read More

Read More

Prairie Village, KS – November 30, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, an Associate Professor of Surgery at the Washington University School of Medicine at Barnes-Jewish Hospital in St. Louis,

Read More

Prairie Village, KS – October 7, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that preliminary clinical results from its first-in-human study of the Amplifi™ Vein Dilation System were presented at the 2021 Vascular Interventional Advances (VIVA) conference. Data were presented during a Late-Breaking Clinical Trial session by Surendra Shenoy, MD-PhD, an Associate Professor of

Read More

Read More

Prairie Village, KS – August 31, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Wendy Sawyer as Senior Vice President of Operations and Quality and Mimi Fitterer as Senior Director of Technology. Sawyer joins Artio with over 30 years of experience in medical device operations, manufacturing, and product development. Most recently, she

Read More

Presentation showcases immediate, complete, and lasting peripheral artery occlusion achieved in a study with company’s new embolization technology Prairie Village, KS – August 10, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the presentation of data highlighting the performance of its Solus Gold Embolization Device during a session on new embolization devices at the 2021 Global

Read More

Novel vein dilation system aims to improve vascular access for hemodialysis patients Prairie Village, KS – July 29, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today it has completed enrollment in its first-in-human study evaluating the company’s Amplifi™ Vein Dilation System. Five patients were treated by Dr. Adrian Ebner, the Head of the Cardiovascular Department

Read More

Company expands leadership team ahead of first US product launch Prairie Village, KS – July 14, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Erdie De Peralta as Vice President of Clinical and Regulatory Affairs and Delane Dale as Senior Director of Quality Assurance. De Peralta and Dale have joined Artio as

Read More

Prairie Village, KS – June 24, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announces the appointment of Abhinav Shukla to the company’s Board of Directors. Shukla joins Artio with more than a decade of experience in transforming operational systems and driving revenue growth in high potential companies. Prior to his Board appointment, Shukla served as

Read More

Prairie Village, KS – June 15, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Jeff Weinrich as Head of Global Sales and Chris Parker as Senior Director of Marketing. Weinrich and Parker have joined Artio to prepare the company for the planned U.S. market release of its first anticipated commercial product, the

Read More

Company to accelerate clinical testing and prepare for commercialization of its broad portfolio of products Prairie Village, KS – April 29, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today the closing of an additional $12 million tranche of Series A financing, bringing the total to $46 million. Led by existing investors Nathaniel and Sarah Hagedorn,

Read More

First-of-its-kind medical device aims to improve vascular access for hemodialysis patients Prairie Village, KS – January 27, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today that it has successfully completed the first human use of its AmplifiTM Vein Dilation System. The first clinical procedure was performed by Adrian Ebner, MD, the Head of the Cardiovascular Department

Read More

Prairie Village, KS – December 8, 2020 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the appointment of John Ayres to the position of Vice President of Corporate Development and General Counsel. Mr. Ayres comes to Artio with fifteen years of legal and financial experience in healthcare, including expertise in corporate governance, securities law, initial public

Read More

Proven leader with over 30 years of success developing novel medical devices Prairie Village, KS – September 1, 2020 – Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced it has named Paul Muller to serve as Chief Technology Officer (CTO) and General Manager (GM). Mr. Muller will oversee the development of Artio’s portfolio of products and

Read More

Read More

Fairway, KS – July 23, 2020 – Artio Medical, Inc. (Artio) today announced it has acquired Flow Forward Medical, Inc. (Flow Forward), a medical device company developing innovative methods for establishing and maintaining high-quality vascular access sites to improve outcomes for hemodialysis patients. This stock-for-stock merger transaction in which Flow Forward merged with and into Artio was approved by the Board of Directors and stockholders of both companies. The transaction

Read More

Fairway, KS – April 28, 2020 – Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets today announced the appointment of entrepreneur and businessman Nathaniel Hagedorn to its Board of Directors. As the founder and CEO of NorthPoint Development, Hagedorn has raised over $6.5B in capital and brings nearly two decades of experience in accessing new markets and scaling

Read More

Fairway, KS – April 14, 2020 – Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets has appointed seasoned medical device sales executive Jeff Weinrich to its Board of Directors. Weinrich is currently on the Senior Regional Management Team at Corindus Vascular Robotics, a commercial robotics company developing first-to-market interventional robotic solutions to the peripheral vascular, neurovascular, and cardiology markets

Read More